Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses

Author:

Freitas Brendan T.1,Ahiadorme Daniil A.2ORCID,Bagul Rahul S.1,Durie Ian A.1,Ghosh Samir1,Hill Jarvis2,Kramer Naomi E.3,Murray Jackelyn4,O’Boyle Brady M.1,Onobun Emmanuel2,Pirrone Michael G.1,Shepard Justin D.4,Enos Suzanne1,Subedi Yagya P.1,Upadhyaya Kapil1,Tripp Ralph A.4,Cummings Brian S.13,Crich David12ORCID,Pegan Scott D.5ORCID

Affiliation:

1. Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, 120 W. Green Street, Athens, Georgia 30602, United States

2. Department of Chemistry, University of Georgia, 140 Cedar Street, Athens, Georgia 30602, United States

3. Interdisciplinary Toxicology Program, University of Georgia, Athens, Georgia 30602, United States

4. Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602, United States

5. Division of Biomedical Sciences, University of California Riverside, Riverside, California 92521, United States

Funder

National Institute of Allergy and Infectious Diseases

Sunshine Biopharma

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3